2015
DOI: 10.1186/s12882-015-0090-9
|View full text |Cite
|
Sign up to set email alerts
|

Focal segmental glomerulosclerosis: molecular genetics and targeted therapies

Abstract: Recent advances show that human focal segmental glomerulosclerosis (FSGS) is a primary podocytopathy caused by podocyte-specific gene mutations including NPHS1, NPHS2, WT-1, LAMB2, CD2AP, TRPC6, ACTN4 and INF2. This review focuses on genes discovered in the investigation of complex FSGS pathomechanisms that may have implications for the current FSGS classification scheme. It also recounts recent recommendations for clinical management of FSGS based on translational studies and clinical trials. The advent of ne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
42
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(42 citation statements)
references
References 112 publications
(95 reference statements)
0
42
0
Order By: Relevance
“…Critical is the elimination of other systemic diseases or primary renal diseases that may result in a similar presentation. Many reviews cover various aspects of FSGS and include comprehensive reviews (1)(2)(3)(4), disease mechanisms (5)(6)(7)(8), pediatric disease (9), immunologic aspects (10), treatment in children (11), and treatment in adults (12)(13)(14). We focus here on a practical approach to FSGS assessment on clinical and histopathologic grounds in the context of our current understanding of disease mechanisms and genetics.…”
Section: Introductionmentioning
confidence: 99%
“…Critical is the elimination of other systemic diseases or primary renal diseases that may result in a similar presentation. Many reviews cover various aspects of FSGS and include comprehensive reviews (1)(2)(3)(4), disease mechanisms (5)(6)(7)(8), pediatric disease (9), immunologic aspects (10), treatment in children (11), and treatment in adults (12)(13)(14). We focus here on a practical approach to FSGS assessment on clinical and histopathologic grounds in the context of our current understanding of disease mechanisms and genetics.…”
Section: Introductionmentioning
confidence: 99%
“…Focal segmental glomerular sclerosis (FSGS) is a lesion of the kidney glomerulus that leads to nephrotic syndrome, typically progressing to end stage renal disease [Chen and Liapis, 2015; Jefferson and Shankland, 2014; Rood et al, 2012]. The key targets of this lesion are podocytes, highly specialized epithelial cells that enwrap the glomerular capillaries with highly elaborate foot processes [Jefferson and Shankland, 2014].…”
Section: The Role Of Inf2 In Human Diseasementioning
confidence: 99%
“…Most of these genes can be categorized as those which are related with slit diaphragm structure, actin cytoskeleton of podocytes, or podocyte-glomerular basement membrane interaction through foot processes [37-39]. In addition, a specific channel mutation (see below) has also been identified as a cause of FSGS (Table 1).…”
Section: Genetic Backgroundmentioning
confidence: 99%